Latest Insider Transactions at Gbs Inc. (GBS)
This section provides a real-time view of insider transactions for Gbs Inc. (GBS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GBS Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GBS Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 25
2024
|
Spiro Kevin Sakiris Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,500
+49.77%
|
-
|
|
Sep 25
2024
|
Harry Simeonidis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+49.75%
|
-
|
|
Mar 20
2024
|
Spiro Kevin Sakiris Chief Financial Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
9,394
+32.88%
|
-
|
|
Oct 04
2023
|
Christopher Towers Director |
BUY
Open market or private purchase
|
Direct |
9,090
+47.92%
|
-
|
|
Oct 04
2023
|
Spiro Kevin Sakiris Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
112,727
+48.98%
|
-
|
|
Sep 01
2023
|
Harry Simeonidis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50
+1.18%
|
$50
$1.85 P/Share
|
|
Aug 31
2023
|
Harry Simeonidis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
100
+2.36%
|
$100
$1.92 P/Share
|
|
May 10
2023
|
Spiro Kevin Sakiris Chief Financial Officer |
BUY
Conversion of derivative security
|
Indirect |
2,399
+33.58%
|
$11,995
$5.8 P/Share
|
|
Oct 10
2022
|
Harry Simeonidis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+49.81%
|
-
|
|
Oct 10
2022
|
Jonathan Scott Hurd Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Oct 10
2022
|
Christopher Towers Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+48.7%
|
-
|
|
Oct 10
2022
|
George Margelis Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Oct 10
2022
|
Spiro Kevin Sakiris Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+37.46%
|
-
|
|
Oct 10
2022
|
Lawrence B Fisher Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Oct 10
2022
|
Steven Constantine Boyages Interim CEO and Chairperson |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+50.0%
|
-
|
|
Jun 22
2022
|
Spiro Kevin Sakiris Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+9.05%
|
$0
$0.65 P/Share
|
|
Jun 17
2022
|
Spiro Kevin Sakiris Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,970
+26.1%
|
$0
$0.61 P/Share
|
|
Feb 17
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
576,028
-34.75%
|
$0
$0.51 P/Share
|
|
Feb 16
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-5.69%
|
$0
$0.63 P/Share
|
|
Feb 15
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-5.38%
|
$0
$0.68 P/Share
|
|
Feb 14
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-5.11%
|
$0
$0.7 P/Share
|
|
Feb 11
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-4.86%
|
$0
$0.75 P/Share
|
|
Feb 10
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-4.63%
|
$0
$0.84 P/Share
|
|
Feb 09
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-4.43%
|
$0
$0.86 P/Share
|
|
Feb 08
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-4.24%
|
$0
$0.89 P/Share
|
|
Feb 02
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-4.07%
|
$0
$0.92 P/Share
|
|
Jan 31
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-3.91%
|
$0
$0.9 P/Share
|
|
Jan 28
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-3.76%
|
$0
$0.92 P/Share
|
|
Jan 27
2022
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-3.63%
|
$100,000
$1.0 P/Share
|
|
Dec 30
2021
|
Tom Parmakellis Director |
BUY
Open market or private purchase
|
Direct |
4,500
+32.61%
|
$4,500
$1.55 P/Share
|
|
Dec 17
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
200,000
-6.76%
|
$200,000
$1.49 P/Share
|
|
Dec 16
2021
|
Tom Parmakellis Director |
BUY
Open market or private purchase
|
Direct |
2,800
+36.84%
|
$2,800
$1.69 P/Share
|
|
Dec 06
2021
|
Spiro Kevin Sakiris Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+25.47%
|
$10,000
$1.7 P/Share
|
|
Nov 30
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
250,000
-7.79%
|
$250,000
$1.87 P/Share
|
|
Nov 29
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-3.02%
|
$100,000
$1.69 P/Share
|
|
Nov 24
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-2.93%
|
$100,000
$1.64 P/Share
|
|
Nov 09
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
300,000
-8.09%
|
$600,000
$2.02 P/Share
|
|
Oct 21
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
248,416
-6.28%
|
$496,832
$2.26 P/Share
|
|
Oct 20
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
24,209
-0.61%
|
$48,418
$2.25 P/Share
|
|
Oct 19
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
16,326
-0.41%
|
$32,652
$2.25 P/Share
|
|
Oct 14
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,726
-2.46%
|
$201,452
$2.18 P/Share
|
|
Oct 13
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
58,739
-1.41%
|
$117,478
$2.25 P/Share
|
|
Oct 12
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-2.35%
|
$200,000
$2.13 P/Share
|
|
Oct 08
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
200,000
-4.49%
|
$400,000
$2.3 P/Share
|
|
Sep 28
2021
|
Tom Parmakellis Director |
BUY
Open market or private purchase
|
Direct |
1,000
+33.33%
|
$2,000
$2.4 P/Share
|
|
Sep 28
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
200,000
-4.3%
|
$400,000
$2.48 P/Share
|
|
Sep 24
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
200,000
-4.12%
|
$400,000
$2.66 P/Share
|
|
Sep 23
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-2.02%
|
$200,000
$2.77 P/Share
|
|
Sep 22
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-1.98%
|
$200,000
$2.8 P/Share
|
|
Sep 21
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-1.94%
|
$200,000
$2.83 P/Share
|